Skip to main content
logo

Orion Oyj (ORINY)

OTCMKTS · Delayed Price · Currency is USD
40.80
+0.12 (0.30%)
Aug 1, 2025, 3:37 PM EDT

Intra-Cellular Therapies Revenue

Orion Oyj had revenue of 416.50M EUR in the quarter ending June 30, 2025, with 26.90% growth. This brings the company's revenue in the last twelve months to 1.68B, up 33.19% year-over-year. In the year 2024, Orion Oyj had annual revenue of 1.54B with 29.65% growth.

Revenue (ttm)
1.68B EUR
Revenue Growth
+33.19%
P/S Ratio
5.79
Revenue / Employee
432.14K EUR
Employees
3,880
Market Cap
11.40B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.54B352.70M29.65%
Dec 31, 20231.19B-150.90M-11.26%
Dec 31, 20221.34B299.60M28.78%
Dec 31, 20211.04B-37.10M-3.44%
Dec 31, 20201.08B27.10M2.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Endo, Inc.1.73B
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
Silence Therapeutics27.70M
Revenue Rankings

Orion Oyj News

More News